论文部分内容阅读
Backgrounds: Cardioversion for atrial fibrillation(AF) is the most effective treatment for the restoration of sinus rhythm(SR). Recently, an elevated level of hs-CRP has been shown to be associated with AF burden, suggesting that inflammation increases the propensity for persistence of AF. We examined whether the level of high-sensitivity C-reactive protein(hs-CRP) was predictive of the outcome of cardioversion for AF. Methods and results: One hundred and six patients with a history of symptomatic AF lasting ≥ 1 day(age 63± 14 years, mean± S.D.) underwent cardioversion. Echocardiography and hs-CRP assay were performed immediately prior to cardioversion. SR was restored in 84 patients(79% ). By using selected cutoff values,multiple discriminant analysis revealed significant associations between successful cardioversion and a shorter duration of AF(AF duration≤ 36 days, odds ratio(OR), 0.98; 95% confidence interval(CI), 0.97-0.99), smaller left atrial diameter(left atrial diameter ≤ 40 mm, OR 0.82, 95% CI 0.71-0.94), better-preserved left ventricular ejection fraction(left ventricular ejection fraction ≥ 60% , OR 0.92, 95% CI 0.86-0.99), and lower hs-CRP level(hs-CRP ≤ 0.12 mg/dL, OR 0.33, 95% CI 0.21-0.51). During a follow-up period of 140± 144 days, AF recurred in 64 patients(76% ). By using a cutoff value of hs-CRP ≥ 0.06 mg/dL, Cox proportional-hazards regression model found that only hs-CRP level was an independent predictor of AF recurrence(OR 5.30, 95% CI 2.46-11.5) after adjustment for coexisting cardiovascular risks. When patients were divided by the hs-CRP level of 0.06 mg/dL, percentage of maintenance of SR below and above the cutoff was 53% and 4% , respectively(log-rank test, p< 0.0001). Conclusions: hs-CRP level determined prior to cardioversion represents an independent predictor of both successful cardioversion for AF and the maintenance of SR after conversion.
Backgrounds: Cardioversion for atrial fibrillation (AF) is the most effective treatment for the restoration of sinus rhythm (SR). Recently, an elevated level of hs-CRP has been shown to be associated with AF burden, suggesting that inflammation increases the propensity for persistence of AF. We examined whether the level of high-sensitivity C-reactive protein (hs-CRP) was predictive of the outcome of cardioversion for AF. Methods and results: One hundred and six patients with a history of symptomatic AF lasting ≥ 1 Echocardiography and hs-CRP assays were performed immediately prior to cardioversion. SR was restored in 84 patients (79%). By using selected cutoff values, multiple discriminant analysis learned significant associations between cardioversion and shorter duration of AF (AF duration ≤ 36 days, odds ratio (OR), 0.98; 95% confidence interval (CI), 0.97-0.99), smaller left atrial diameter ≤ 40 mm, OR 0.82, 95% CI 0.71-0.94), better-preserved left ventricular ejection fraction (left ventricular ejection fraction ≥ 60%, OR 0.92, 95% CI 0.86-0.99), and lower hs-CRP level -CRP ≤ 0.12 mg / dL, OR 0.33, 95% CI 0.21-0.51). During a follow-up period of 140 ± 144 days, AF recurred in 64 patients (76%). By using a cutoff value of hs-CRP Cox proportional-hazards regression model found that only hs-CRP level was an independent predictor of AF recurrence (OR 5.30, 95% CI 2.46-11.5) after adjustment for coexisting cardiovascular risks. When patients were divided by the hs-CRP level of 0.06 mg / dL, percentage of maintenance of SR below and above the cutoff was 53% and 4%, respectively (log-rank test, p <0.0001). Conclusions: hs-CRP level determined prior to cardioversion an independent predictor of both successful cardioversion for AF and the maintenance of SR after conversion.